HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T cell repertoire development in XSCID dogs following nonconditioned allogeneic bone marrow transplantation.

Abstract
Dogs with X-linked severe combined immunodeficiency (XSCID) can be successfully treated by bone marrow transplants (BMT) resulting in full immunologic reconstitution and engraftment of both donor B and T cells without the need for pretransplant conditioning. In this study, we evaluated the T cell diversity in XSCID dogs 4 months to 10.5 years following BMT. At 4 months posttransplantation, when the number of CD45RA+ (naïve) T cells had peaked and plateaued, the T cells in the transplanted dogs showed the same complex, diverse repertoire as those of normal young adult dogs. A decline in T cell diversity became evident approximately 3.5 years posttransplant, but the proportion of Vbeta families showing a polyclonal Gaussian spectratype still predominated up to 7.5 years posttransplant. In 2 dogs evaluated at 7.5 and 10.5 years posttransplant, >75% of the Vbeta families consisted of a skewed or oligoclonal spectratype that was associated with a CD4/CD8 ratio of <0.5. The decline in the complexity of T cell diversity in the transplanted XSCID dogs is similar to that reported for XSCID patients following BMT. However, in contrast to transplanted XSCID boys who show a significant decline in their T cell diversity by 10 to 12 years following BMT, transplanted XSCID dogs maintain a polyclonal, diverse T cell repertoire through midlife.
AuthorsWilliam Vernau, Brian J Hartnett, Douglas R Kennedy, Peter F Moore, Paula S Henthorn, Kenneth I Weinberg, Peter J Felsburg
JournalBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation (Biol Blood Marrow Transplant) Vol. 13 Issue 9 Pg. 1005-15 (Sep 2007) ISSN: 1083-8791 [Print] United States
PMID17697962 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Receptors, Antigen, T-Cell
Topics
  • Animals
  • Bone Marrow Transplantation
  • CD4-CD8 Ratio
  • Dogs
  • Follow-Up Studies
  • Gene Rearrangement, T-Lymphocyte
  • Hematopoiesis
  • Receptors, Antigen, T-Cell (genetics)
  • T-Lymphocytes (cytology, immunology)
  • Transplantation, Homologous
  • X-Linked Combined Immunodeficiency Diseases (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: